Another Step in XPHOZAH’s Path to Patients. A Message from the President and CEO, Mike Raab
Today represents another important milestone in Ardelyx’s journey to bring XPHOZAH, our novel mechanism phosphate absorption inhibitor, to patients with chronic kidney disease on dialysis suffering...